期刊文献+

阿霉素和吡喃阿霉素对乳腺癌患者心脏毒性的临床观察 被引量:1

Comparative Study of Cardiotoxicity of Anthracycline-containing of CAF and CTF Regimens in Patients with Breast Cancer
下载PDF
导出
摘要 目的:探讨阿霉素和吡喃阿霉素对乳腺癌患者心脏毒性的临床观察。方法:对72例局部晚期乳腺癌患者随机分成2组,均是用环磷酰胺+阿霉素+5-氟脲嘧啶及环磷酰胺+吡喃阿霉素+5-氟脲嘧啶的联合化疗方案,通过检测患者心电图及心功能的变化,临床对照观察患者的心脏毒性反应。结果:吡喃阿霉素组较少出现心电图异常,4例心电图呈现一过性改变,较快2周恢复正常。阿霉素组,6例心电图改变,有4例在2周内恢复正常,1例有所减轻,但1例在1月后无改善,经超声心动图检测为充血性心力衰竭。结论:大多数患者能够较好地耐受阿霉素和吡喃阿霉素的化疗,吡喃阿霉素比阿霉素稍好,但经统计无显著性意义(P>0.05)。 Objective: To evaluate and compare the cardiotoxicity of THP regimens or ADM regimens in patients with breast cancer. Methods.76 patients with local advanced breast cancer were randomized into THP regimens (group CTF)or ADM regimens(group CAF)were observed for the cardiotoxity according to the change of electrocardiogram and echocardiography. Patients in both groups were well-matched with baseline disease characteristics(P〉0.05 ). Results: In CTF group, there were 4 patients had transient electrocardiogram change and quickly recovered in 2 weeks. Six patients with abnormal electrocardiogram in the CAF group were detected, and among them 4 patients recovered in 2 weeks,a patient's symptom relieved partially and a patient was diagnosed as congestive heart failure two weeks later by echocardiography. Conclusion: The most patients have similar tolerance in two groups, P〉0.05. It looks that the CTF group are litter better than CAF group, but there was no statistically significant (P〉0.05).
出处 《实用临床医学(江西)》 CAS 2007年第2期19-20,24,共3页 Practical Clinical Medicine
关键词 乳腺癌 心脏毒性 阿霉素 吡喃阿霉素 breast neoplasms cardiotoxicity pirarubicin doxorubicin
  • 相关文献

参考文献5

  • 1Janusz W,Ewa L N,Krzysztof LK,et al.Anthracycline-induced Cardiotoxicity:Clinical Course,Risk Factors,Pathogenesis,Detection and Prevention-review of the Literature[J].Med Sci Monit,2000,62:411-420.
  • 2Pai V B,Nahata M C.Cardiotoxicity of Chemotherapeutic Agents:Incidence,Treatment and Prevention[J].Drug Saf,2000,22 4:263-302.
  • 3曲洪澜,王丽娟,关琦.紫杉醇与表阿霉素联合治疗晚期乳腺癌的临床观察[J].临床肿瘤学杂志,2003,8(5):345-347. 被引量:15
  • 4徐兵河.改变乳腺癌临床实践的重要临床试验的回顾与评述[J].中国癌症杂志,2005,15(5):408-412. 被引量:22
  • 5Tone H,Kurebe M,Takeuchi T,et al.Experimental Studies on [2 R-4-O-etrahydropyranyl-adriamycin THP.In Kuemmerle HP ed Advance in Experimental and Clinical Chemotherapy 15th International Congress of Chemotherapy.Workshop on Pirarubicin July,19-24,1987,Instanbul,Turkey.Landsbeg/Lech:Ecomed,1988:1-9.

二级参考文献21

  • 1Horwitz SB, Cohen D, Rao S, et al. Taxel: Mechanisms of action and resistance [ J ]. J Nail Cancer Inst, 1993,15 : 15 - 61.
  • 2Sudat, Takahashi T, Golstein P, et al. Moleculor Cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family [ J ]. cell, 1993,75 (6) : 1169.
  • 3Gianni, Munzone E, Capri G, et al. Paclitaxel by 3-hour infusion with bolus doxombicin in women with untreated metastaic breast Cancer:high antitumor efficacy and cardiac effects in a dose-finding end sequence-finding study[ J]. J clin oncol 1995,13:2688 -2699.
  • 4Sledge G W Jr Doxorybicin/pacltaxel combination chemotherapy for metastatic breast cancer: the Easten Cooperative Oncology Group experience[ J]. Semin Oncol 1995,22 : 123 - 125.
  • 5Rowinsky EK, Eisentiauer EA, chaudhry V, et al. clinical toxicities, encountered with toxel[ J ]. semin oncol, 1993,20:1.
  • 6Bonadonna G, Valagussa PM,Olitemi A, et al. Adjuvant cyclophoshamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up [ J ]. N Engl J Med, 1995,332 ( 14 ) :901-906.
  • 7Bonadonna G, Brusamolion E, Valagussa P, et al. Combination chemotherapy as an adjuvant treatment in operable breast cancer[ J]. N Engl J Med, 1976,294( 8 ) :405-410.
  • 8Bonadonna G, Moliterni A, Zambetti M, et al. 30 years' follow up of randomized studies of adjuvant CMF in operable breast cancer: cohort study [ J ]. Br Med J, 2005,330 ( 7485 ): 217 -220.
  • 9Fisher B, Brown AM, Dimitrov NV, et al. Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results from the National Surgical Adjuvant Breast and Bowel Project B-15 [ J ]. J Clin Oncol,1990,8 ( 9 ): 1483-1496.
  • 10Early Breast Cancer Trialist' s Collaborative Group. Polychemotherapy for early breast cancer: an overview of the randomized trials [ J ]. Lancet, 1998,352 ( 9132 ) :930-932.

共引文献35

同被引文献11

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部